According to a report by Infiniti Research, cosmetic facial injectables are increasingly being used to treat chronic, non-cosmetic conditions and to improve patients’ quality of life.
Cosmetic and beauty-related uses for facial injectables—such as Botox, hyaluronic acid, and collagen—include smoothing out lines and wrinkles, and filling depressions that patients deem to be lacking in volume. Botox dominated the global facial injectables market in 2016, accounting for $1.82 billion in revenue, according to a media release from Infiniti Research.
The market for cosmetic injectables has been thriving in recent years, due to growing awareness of anti-aging treatments and the increased affordability of non-invasive cosmetic procedures, as well as the increasing non-cosmetic uses that medicine has found for them, Infiniti Research notes.
However, according to the report, the market for non-cosmetic uses of injectables is also thriving.
Botox is increasingly being used to treat Parkinson’s disease, Bell’s palsy, cerebral palsy, and crossed eyes. In addition, hyaluronic acid and collagen are becoming popular treatments for joint disorders, including osteoarthritis. Hyaluronic acid has recently been approved for use in eye surgeries, including corneal transplants, to compensate for dryness and lost natural fluids, the release adds.
For more information, visit Infiniti Research.
[Source(s): Infiniti Research, Business Wire]